These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31374291)

  • 1. Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth.
    Li X; He S; Tian Y; Weiss RM; Martin DT
    Cell Signal; 2019 Nov; 63():109381. PubMed ID: 31374291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer.
    Xu S; Grande F; Garofalo A; Neamati N
    Mol Cancer Ther; 2013 Jun; 12(6):937-49. PubMed ID: 23536726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target.
    Martin DT; Shen H; Steinbach-Rankins JM; Zhu X; Johnson KK; Syed J; Saltzman WM; Weiss RM
    Mol Cancer Ther; 2019 Feb; 18(2):413-420. PubMed ID: 30381445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
    Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
    Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer.
    Cronise KE; Hernandez BG; Gustafson DL; Duval DL
    Mol Pharmacol; 2019 Jul; 96(1):36-46. PubMed ID: 31048548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis.
    He S; Li G; Schätzlein AG; Humphrey PA; Weiss RM; Uchegbu IF; Martin DT
    Cell Signal; 2021 May; 81():109931. PubMed ID: 33529758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium Selenite Enhanced the Anti-proliferative Effect of MEK-ERK Inhibitor in Thyroid Cancer Cells.
    Kim JB; Yang EY; Woo J; Kwon H; Lim W; Moon BI
    In Vivo; 2020; 34(1):185-190. PubMed ID: 31882478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.
    Salizzato V; Borgo C; Cesaro L; Pinna LA; Donella-Deana A
    Oncotarget; 2016 Apr; 7(14):18204-18. PubMed ID: 26919095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of hypoxia-inducible factor antisense as a novel approach to treat ovarian cancer.
    Lu T; Tang J; Shrestha B; Heath BR; Hong L; Lei YL; Ljungman M; Neamati N
    Theranostics; 2020; 10(15):6959-6976. PubMed ID: 32550915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells.
    Chen RJ; Ho YS; Guo HR; Wang YJ
    Toxicol Sci; 2010 May; 115(1):118-30. PubMed ID: 20106947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720.
    Jiang CC; Lai F; Thorne RF; Yang F; Liu H; Hersey P; Zhang XD
    Clin Cancer Res; 2011 Feb; 17(4):721-30. PubMed ID: 21088259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells.
    Kassouf W; Dinney CP; Brown G; McConkey DJ; Diehl AJ; Bar-Eli M; Adam L
    Cancer Res; 2005 Nov; 65(22):10524-35. PubMed ID: 16288045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144.
    Pozios I; Hering NA; Guenzler E; Arndt M; Elezkurtaj S; Knösel T; Bruns CJ; Margonis GA; Beyer K; Seeliger H
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):271-280. PubMed ID: 36495330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of MEK/ERK 1/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia.
    Wang ZQ; Wu DC; Huang FP; Yang GY
    Brain Res; 2004 Jan; 996(1):55-66. PubMed ID: 14670631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
    Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
    Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway.
    Hsu FS; Wu JT; Lin JY; Yang SP; Kuo KL; Lin WC; Shi CS; Chow PM; Liao SM; Pan CI; Hong JY; Chang HC; Huang KH
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mitogen-activated protein kinase signaling pathway sensitizes breast cancer cells to endoplasmic reticulum stress-induced apoptosis.
    Yang F; Tang XY; Liu H; Jiang ZW
    Oncol Rep; 2016 Apr; 35(4):2113-20. PubMed ID: 26796921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
    Yip-Schneider MT; Schmidt CM
    Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.